MAPT and Alzheimer disease: A recent study identified CSF microtubule-binding region of tau containing the residue 243 (MTBR-tau43) as a novel fluid biomarker of tau tangle pathology, holding potential alongside P-tau217 and other biomarkers for detailed molecular staging of AD, although more work is needed to examine its performance as a more accessible blood test (29).